Results 61 to 70 of about 359 (95)

[The guidelines for the diagnosis and treatment of Castleman disease in China (2025)]. [PDF]

open access: yesZhonghua Xue Ye Xue Za Zhi
Hematological Rare Disease Academic Group   +3 more
europepmc   +1 more source

[Clinical characteristics of 11 patients with chronic lymphocytic leukemia with t (14;19) (q32;q13)]. [PDF]

open access: yesZhonghua Xue Ye Xue Za Zhi, 2023
Cui CH   +10 more
europepmc   +1 more source

[Chinese expert consensus on the diagnosis and treatment of plasma cell leukemia (2025)]. [PDF]

open access: yesZhonghua Xue Ye Xue Za Zhi
Multiple Myeloma Expert Committee of Chinese Society of Clinical Oncology (CSCO)   +5 more
europepmc   +1 more source

[Progress in preparation and application of sodium alginate microspheres]. [PDF]

open access: yesSheng Wu Yi Xue Gong Cheng Xue Za Zhi, 2023
Liu X   +6 more
europepmc   +1 more source

[Chinese expert consensus on the diagnosis and treatment of human immunodeficiency virus infection related diffuse large B cell lymphoma (2025)]. [PDF]

open access: yesZhonghua Xue Ye Xue Za Zhi
Lymphoid Disease Group   +5 more
europepmc   +1 more source

[Safety and efficacy of donor-derived chimeric antigen receptor T-cell therapy in patients with relapsed B-cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation]. [PDF]

open access: yesZhonghua Xue Ye Xue Za Zhi
Zhuo YQ   +15 more
europepmc   +1 more source

[Chinese expert consensus on standard procedures for the outpatient management of patients with multiple myeloma (2025)]. [PDF]

open access: yesZhonghua Xue Ye Xue Za Zhi
Plasma Cell Disease Group   +3 more
europepmc   +1 more source

[Chinese expert consensus on the diagnosis and treatment of large granular lymphocytic leukemia (2026)]. [PDF]

open access: yesZhonghua Xue Ye Xue Za Zhi
Hematological Oncology Committee of China Anti-Cancer Association   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy